Overview

Study of Asenapine in Elderly Subjects With Psychosis (A7501021)(P05717)

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
This study evaluates the safety and tolerability of Asenapine in elderly patients with psychosis.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Asenapine